Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLMO-guided Melatonin Timing in DSWPD
NCT03715465Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Feb 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in delayed sleep-wake phase disorder (DSPD), sponsored by University of Michigan. Started Feb 2019; status: completed.
02
Drugs
melatonin
03
Conditions
delayed sleep-wake phase disorder (DSPD)
Beyond the preview
Go deeper on NCT03715465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715465.